HER2 testing
Accurate assessment of tumour HER2-status is essential to ensure that all patients who may benefit from Herceptin (trastuzumab) are correctly identified.
Importance of HER2 testing in breast cancer
The current standard of care for patients with breast cancer includes a requirement to know HER2 status prior to making treatment decisions.
HER2 testing in gastric cancer
The accurate identification of HER2-positive gastric tumours is essential for determining potential eligibility for the ToGA trial.
Methodologies
HER2 status can be assessed using techniques that determine either the level of HER2 protein expression or HER2 gene amplification.
Quality control and quality assurance
A high standard of inter- and intra-laboratory validation is required for accurate HER2 status determination
- Disclaimer: Herceptin.net is a comprehensive resource for healthcare professionals outside the US. If you are a US resident please visit www.herceptin.com. The information on this site is not country-specific and may contain information that is outside the approved indications in the country in which you are located.